Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Interferon Research
|
September 1, 1989
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a
L M Itri, M I Sherman, A V Palleroni, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Lancet (London, England)
|
January 15, 1983
Antibodies to human leucocyte interferons in cancer patients
P W Trown, M J Kramer, R A Dennin, et al.
Journal of Biological Standardization
|
July 1, 1987
The detection of antibodies to recombinant interferon alfa-2a in human serum
U Hennes, W Jucker, E A Fischer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 1997
Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a
A V Palleroni, A Aglione, M Labow, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Antitumor activity of interleukin 12 in preclinical models
M J Brunda, L Luistro, L Rumennik, et al.
Cancer Research
|
February 1, 1980
Relationship between binding affinities to cellular retinoic acid-binding protein and in vivo and in vitro properties for 18 retinoids
P W Trown, A V Palleroni, O Bohoslawec, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Interferon Research
|
September 1, 1989
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a
L M Itri, M I Sherman, A V Palleroni, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Lancet (London, England)
|
January 15, 1983
Antibodies to human leucocyte interferons in cancer patients
P W Trown, M J Kramer, R A Dennin, et al.
Journal of Biological Standardization
|
July 1, 1987
The detection of antibodies to recombinant interferon alfa-2a in human serum
U Hennes, W Jucker, E A Fischer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
July 1, 1997
Interferon immunogenicity: preclinical evaluation of interferon-alpha 2a
A V Palleroni, A Aglione, M Labow, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Antitumor activity of interleukin 12 in preclinical models
M J Brunda, L Luistro, L Rumennik, et al.
Cancer Research
|
February 1, 1980
Relationship between binding affinities to cellular retinoic acid-binding protein and in vivo and in vitro properties for 18 retinoids
P W Trown, A V Palleroni, O Bohoslawec, et al.
Page
of 2